programma definitivo - Società italiana di neurologia
programma definitivo - Società italiana di neurologia
programma definitivo - Società italiana di neurologia
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
717. IDENTIFICATION OF NOVEL BIOMARKERS OF DISEASE ACTIVITY IN<br />
MULTIPLE SCLEROSIS<br />
S. PONTECORVO, S. ZAMBONI, A. D’AMBROSIO, F. DELUNARDO, M. MORREALE, M.<br />
DIOCIAIUTI, D. SOLDATI, A. FRANCIA, P. MARGUTTI (Roma)<br />
718. THERAPEUTIC APPROACHES, SOCIAL AND FAMILY ISSUES OF ITALIAN<br />
MULTIPLE SCLEROSIS PATIENTS<br />
T. SACCO, C. COLLICELLI, K. VACCARO, T. MANACORDA, S. BASTEN, C. POZZILLI, M.<br />
BATTAGLIA (Roma, Genova)<br />
719. OBJECTIVE EVALUATION OF WALKING DISTANCE AND CORRELATION<br />
WITH EDSS IN AMBULATORY MS PATIENTS<br />
G. LIBERATORE, S. MAIDA, F. MARTINELLI BONESCHI, M. FALAUTANO, G. COMI, V.<br />
MARTINELLI (Milano)<br />
720. BRAIN ATROPHY AND RETINAL NERVE FIBER LAYER THINNING IN<br />
MULTIPLE SCLEROSIS: A LONGITUDINAL CORRELATION STUDY<br />
S. BORRELLI, A. BISECCO, R. SACCO, S. BONAVITA, L. LAVORGNA, N. ROSA, M. LANZA,<br />
M. CIRILLO, G. TEDESCHI, A. GALLO (Napoli)<br />
721. CLINICAL AND MRI PARAMETERS IN RRMS PATIENT TREATED WITH<br />
FINGOLIMOD AFTER NATALIZUMAB. A 18 MONTH-FOLLOW UP<br />
L. FEDERLE, F. RINALDI, S. MIANTE, D. SEPPI, M. PUTHENPARAMPIL, M. ATZORI, A.<br />
FAVARETTO, I. MATTISI, P. PERINI, P. GALLO (Padova)<br />
722. EPSTEIN-BARR NUCLEAR ANTIGEN-2 GENETIC VARIANTS IN MULTIPLE<br />
SCLEROSIS AND HEALTHY DONORS<br />
R. MECHELLI, C. POLICANO, R. UMETON, G. COARELLI, V. ANNIBALI, S. ROMANO,<br />
A. FORNASIERO, C. MATTEI, G. RISTORI, M. SALVETTI (Roma)<br />
723. ATTITUDES TOWARDS PARTICIPATION IN MS CLINICAL TRIALS:<br />
INFLUENCING FACTORS AND POSSIBLE SOLUTIONS<br />
S. MAIDA, M. RODEGHER, G. DALLA COSTA, M. FALAUTANO, G. COMI, V. MARTINELLI<br />
(Milano)<br />
724. CAN FINGOLIMOD TREATMENT INFLUENCE DISEASE PROGRESSION<br />
AFTER NATALIZUMAB DISCONTINUATION<br />
M.J. MESSINA, M. RODEGHER, D. BARONCINI, M. ROCCA, M. FILIPPI, S. MAIDA,<br />
M. RADAELLI, M. COPETTI, V. MARTINELLI, A. GHEZZI, G. COMI (Milano, San Giovanni<br />
Rotondo - FG, Gallarate - VA)<br />
725. INFLUENCE ON DISEASE-MODIFYING-TREATMENT CHOICE OF RISK<br />
PERCEPTION AND PROPENSITY IN A SINGLE-CENTRE COHORT OF<br />
ITALIAN MULTIPLE SCLEROSIS PATIENTS<br />
F. SANGALLI, V. BARCELLA, M. RADAELLI, L. FERRÈ, L. MOIOLA, M. FALAUTANO, G.<br />
COMI, V. MARTINELLI (Milano)<br />
726. THE BLINK REFLEX TEST: CLINICAL AND RADIOLOGICAL CORRELATIONS<br />
IN MULTIPLE SCLEROSIS PATIENTS<br />
M. TROTTA, G. DONZUSO, S. BARONE, A. AUGIMERI, R. PALETTA, B. VESCIO, T. TALLARICO,<br />
M. CRETELLA, R. NISTICÒ, P. VALENTINO, A. QUATTRONE (Germaneto - CZ)<br />
727. MASS SPECTROMETRY BASED METABONOMICS OF THE CEREBROSPINAL<br />
FLUID HIGHLIGHTS A CORRELATION BETWEEN POLAR LIPIDS AND<br />
CARNITINES LEVELS IN MULTIPLE SCLEROSIS PATIENTS<br />
M. DI IOIA, D. PIERAGOSTINO, C. ROSSI, M. ZUCCHELLI, C. DI ILIO, A. LUGARESI,<br />
G. DE LUCA, D. FARINA, P. SACCHETTA, A. URBANI, P. DEL BOCCIO (Chieti, Roma)<br />
728. A SSA-AB-ASSOCIATED CNS VASCULITIS MIMICKING MULTIPLE<br />
SCLEROSIS. A CASE REPORT<br />
A. FAVARETTO, M. ATZORI, L. SANTELLI, I. ROSELLINI, L. FEDERLE, M. PUTHENPARAMPIL,<br />
D. SEPPI, F. RINALDI, I. MATTISI, P. PERINI, P. GALLO (Padova)<br />
5<br />
N<br />
O<br />
V<br />
E<br />
M<br />
B<br />
R<br />
E<br />
•<br />
A<br />
R<br />
E<br />
A<br />
P<br />
O<br />
S<br />
T<br />
E<br />
R<br />
189
Change language